WHOOP Unite and Ashley Addiction Treatment Partner to Break New Ground in Research and Patient Care

Ashley Addiction Treatment leverages newly launched WHOOP Gateway to advance evidence-based treatments and physiological data collection.

Ashley Treatment logo

Today, WHOOP, the human performance company, and Ashley Addiction Treatment (Ashley), a nationally-recognized leader in evidence-based treatment of substance use disorders, announce a new research partnership to study recovery and relapse by leveraging objective health data from WHOOP Unite alongside subjective patient feedback. In support of these efforts, WHOOP launched the WHOOP Gateway, an innovative hardware and software solution that enables healthcare providers to tap into 24/7 patient physiological insights.

Ashley is the first customer to use WHOOP Unite in conjunction with the WHOOP Gateway for cutting-edge patient support and research. The WHOOP Gateway uses Bluetooth to retrieve biometric data from WHOOP wearable technology and transmit it to WHOOP Unite without the need for a mobile phone. WHOOP Unite is a comprehensive solution dedicated to supporting organizations with coaching, insights, and health programs. The platform helps leaders make policy and protocol changes based on the aggregated data of individual end users.

“At Ashley, we are passionate about providing state-of-the-art care to every person who walks through our doors, which is why advancing the way we conduct research and invest in technology remains at the forefront of everything we do,” said Greg Hobelmann, M.D., M.P.H., co-CEO and president of Ashley. “WHOOP Unite provides a holistic view of patients’ biometric data impacting their treatment, and WHOOP Gateway is the critical link to collecting a large dataset since our patients do not have access to mobile phones during treatment. The ability to gather this type of pivotal health information is a game-changer for our industry and Ashley’s one-of-its-kind database that’s enabling us to change the face of addiction medicine.”

According to the National Institute on Drug Abuse, up to an estimated 60 percent of individuals relapse while in recovery. Ashley is building and expanding its research efforts to better understand the cause of relapse and identify new treatment protocols to reduce stress triggers while leading to better outcomes for its patients.

To further its ability to support organizations like Ashley as well as patients, providers and payers across the healthcare ecosystem, WHOOP recently hired Dr. Patrick Carroll, M.D., the company’s first Chief Medical Officer. Dr. Carroll previously served as Chief Medical Officer of the virtual care company Vida Health and the telehealth company Hims & Hers. Prior to that, he served as Group Vice President and Chief Medical Officer of Walgreens.

“WHOOP Unite is pushing the healthcare industry forward with its innovative solutions like the WHOOP Gateway and efforts to improve patient outcomes as exemplified by this partnership with Ashley Addiction Treatment,” said Dr. Patrick Carroll, Chief Medical Officer at WHOOP. “WHOOP has the power to positively impact the health of its members and transform the way we approach wellness at scale.” 

Back to Top